Myomo Inc. (MYO) financial statements (2020 and earlier)

Company profile

Business Address ONE BROADWAY
CAMBRIDGE, MA 02142
State of Incorp. DE
Fiscal Year End December 31
SIC 3842 - Orthopedic, Prosthetic, and Surgical Appliances and Supplies (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments44797912
Cash and cash equivalents44797912
Receivables0000000
Inventory, net of allowances, customer advances and progress billings0000000
Inventory0000000
Deferred costs  00000
Other undisclosed current assets1111110
Total current assets:6681181013
Noncurrent Assets
Property, plant and equipment0000000
Restricted cash and investments0000000
Other undisclosed noncurrent assets0000000
Total noncurrent assets:0000000
TOTAL ASSETS:7691181113
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:2111221
Accounts payable0001000
Accrued liabilities0000000
Employee-related liabilities1110111
Other undisclosed accounts payable and accrued liabilities0      
Deferred revenue00  
Debt2      
Derivative instruments and hedges, liabilities0000000
Deferred revenue and credits0
Contract with customer, liability00   
Other undisclosed current liabilities 00000 
Total current liabilities:4212222
Noncurrent Liabilities
Long-term debt and lease obligation1      
Long-term debt, excluding current maturities1      
Liabilities, other than long-term debt0     0
Deferred revenue and credits0
Deferred revenue0   
Other undisclosed noncurrent liabilities 0   0 
Total noncurrent liabilities:10   00
Total liabilities:5212222
Stockholders' equity
Stockholders' equity attributable to parent247106911
Common stock0000000
Treasury stock, value(0)(0)(0)(0)(0)(0)(0)
Additional paid in capital58585858525251
Accumulated deficit(56)(53)(51)(48)(45)(43)(40)
Total stockholders' equity:247106911
TOTAL LIABILITIES AND EQUITY:7691181113

Income statement (P&L) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Revenues2111111
Cost of revenue(0)(0)(0)(0)(0)(0)(0)
Cost of goods and services sold(0)  (0)(0)  
Gross profit:1011100
Operating expenses(4)(3)(3)(3)(3)(3)(3)
Operating loss:(3)(3)(3)(3)(3)(3)(3)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
(0)000000
Other undisclosed loss from continuing operations before equity method investments, income taxes(0)      
Loss from continuing operations before income taxes:(3)(3)(3)(3)(3)(3)(3)
Other undisclosed income from continuing operations3   3  
Income (loss) before gain (loss) on sale of properties:0(3)(3)(3)(0)(3)(3)
Other undisclosed net loss(3)   (3)  
Net loss available to common stockholders, diluted:(3)(3)(3)(3)(3)(3)(3)

Comprehensive Income ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Net loss:(3)(3)(3)(3)(3)(3)(3)
Comprehensive loss, net of tax, attributable to parent:(3)(3)(3)(3)(3)(3)(3)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: